PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Myog
|
ENSMUSG00000026459.6 | Myog |
Tcf12
|
ENSMUSG00000032228.17 | Tcf12 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Myog | mm39_v1_chr1_+_134217727_134217753 | 0.37 | 1.6e-03 | Click! |
Tcf12 | mm39_v1_chr9_-_72019053_72019103 | 0.08 | 5.2e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_121637505 | 31.53 |
ENSMUST00000138157.8
|
Frmd5
|
FERM domain containing 5 |
chr2_-_121637469 | 28.89 |
ENSMUST00000110592.2
|
Frmd5
|
FERM domain containing 5 |
chr1_+_75483721 | 26.56 |
ENSMUST00000037330.5
|
Inha
|
inhibin alpha |
chr8_+_94879235 | 25.75 |
ENSMUST00000034211.10
ENSMUST00000211930.2 ENSMUST00000211915.2 |
Mt3
|
metallothionein 3 |
chr8_+_31581635 | 23.02 |
ENSMUST00000161713.2
|
Dusp26
|
dual specificity phosphatase 26 (putative) |
chr3_+_75464837 | 22.72 |
ENSMUST00000161776.8
ENSMUST00000029423.9 |
Serpini1
|
serine (or cysteine) peptidase inhibitor, clade I, member 1 |
chr7_-_30826184 | 22.20 |
ENSMUST00000211945.2
|
Scn1b
|
sodium channel, voltage-gated, type I, beta |
chr1_-_75482975 | 21.76 |
ENSMUST00000113567.10
ENSMUST00000113565.3 |
Obsl1
|
obscurin-like 1 |
chr2_+_14878480 | 21.71 |
ENSMUST00000114719.7
|
Cacnb2
|
calcium channel, voltage-dependent, beta 2 subunit |
chr7_+_121888520 | 21.54 |
ENSMUST00000064989.12
ENSMUST00000064921.5 |
Prkcb
|
protein kinase C, beta |
chr11_+_77353218 | 20.91 |
ENSMUST00000102493.8
|
Coro6
|
coronin 6 |
chr11_-_120538928 | 19.66 |
ENSMUST00000239158.2
ENSMUST00000026134.3 |
Myadml2
|
myeloid-associated differentiation marker-like 2 |
chr7_-_30826376 | 19.16 |
ENSMUST00000098548.8
|
Scn1b
|
sodium channel, voltage-gated, type I, beta |
chr18_+_61058684 | 18.39 |
ENSMUST00000102888.10
ENSMUST00000025519.11 |
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr11_+_110956980 | 17.80 |
ENSMUST00000042970.3
|
Kcnj2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr7_-_24705320 | 17.64 |
ENSMUST00000102858.10
ENSMUST00000196684.2 ENSMUST00000080882.11 |
Atp1a3
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
chr11_+_104468107 | 17.51 |
ENSMUST00000106956.10
|
Myl4
|
myosin, light polypeptide 4 |
chrX_+_133305291 | 17.24 |
ENSMUST00000113228.8
ENSMUST00000153424.8 |
Drp2
|
dystrophin related protein 2 |
chr3_+_146558114 | 16.94 |
ENSMUST00000170055.8
ENSMUST00000037942.11 |
Ttll7
|
tubulin tyrosine ligase-like family, member 7 |
chr3_-_88679881 | 16.91 |
ENSMUST00000090945.5
|
Syt11
|
synaptotagmin XI |
chrX_+_133305529 | 16.23 |
ENSMUST00000113224.9
ENSMUST00000113226.2 |
Drp2
|
dystrophin related protein 2 |
chr13_+_46571910 | 15.59 |
ENSMUST00000037923.5
|
Rbm24
|
RNA binding motif protein 24 |
chr2_+_49509288 | 15.53 |
ENSMUST00000028102.14
|
Kif5c
|
kinesin family member 5C |
chr7_+_3352019 | 15.50 |
ENSMUST00000100301.11
|
Prkcg
|
protein kinase C, gamma |
chr12_+_108300599 | 15.43 |
ENSMUST00000021684.6
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr11_+_31950452 | 15.35 |
ENSMUST00000109409.8
ENSMUST00000020537.9 |
Nsg2
|
neuron specific gene family member 2 |
chr11_-_46203047 | 15.24 |
ENSMUST00000129474.2
ENSMUST00000093166.11 ENSMUST00000165599.9 |
Cyfip2
|
cytoplasmic FMR1 interacting protein 2 |
chr7_+_4122523 | 15.09 |
ENSMUST00000119661.8
ENSMUST00000129423.8 |
Ttyh1
|
tweety family member 1 |
chr16_+_6887689 | 15.01 |
ENSMUST00000229741.2
|
Rbfox1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr11_+_104467791 | 15.00 |
ENSMUST00000106957.8
|
Myl4
|
myosin, light polypeptide 4 |
chr7_+_3352159 | 14.86 |
ENSMUST00000172109.4
|
Prkcg
|
protein kinase C, gamma |
chr5_+_22951015 | 14.58 |
ENSMUST00000197992.2
|
Lhfpl3
|
lipoma HMGIC fusion partner-like 3 |
chr3_-_116047148 | 14.47 |
ENSMUST00000090473.7
|
Gpr88
|
G-protein coupled receptor 88 |
chr7_+_4122555 | 14.45 |
ENSMUST00000079415.12
|
Ttyh1
|
tweety family member 1 |
chr18_+_34973605 | 14.37 |
ENSMUST00000043484.8
|
Reep2
|
receptor accessory protein 2 |
chr2_-_122441719 | 14.31 |
ENSMUST00000028624.9
|
Gatm
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
chr3_-_126792056 | 14.14 |
ENSMUST00000044443.15
|
Ank2
|
ankyrin 2, brain |
chrX_-_71699740 | 13.99 |
ENSMUST00000055966.13
|
Gabra3
|
gamma-aminobutyric acid (GABA) A receptor, subunit alpha 3 |
chr6_-_124840824 | 13.73 |
ENSMUST00000046893.10
ENSMUST00000204667.2 |
Gpr162
|
G protein-coupled receptor 162 |
chr9_-_21963306 | 13.53 |
ENSMUST00000003501.9
ENSMUST00000215901.2 |
Elavl3
|
ELAV like RNA binding protein 3 |
chr8_-_4267260 | 13.52 |
ENSMUST00000168386.9
|
Prr36
|
proline rich 36 |
chr3_-_127019496 | 13.35 |
ENSMUST00000182064.9
ENSMUST00000182452.8 |
Ank2
|
ankyrin 2, brain |
chr6_+_118043307 | 13.09 |
ENSMUST00000203804.3
ENSMUST00000203482.2 |
Rasgef1a
|
RasGEF domain family, member 1A |
chr14_-_76794103 | 13.00 |
ENSMUST00000064517.9
ENSMUST00000228055.2 |
Serp2
|
stress-associated endoplasmic reticulum protein family member 2 |
chr15_+_97990431 | 12.99 |
ENSMUST00000229280.2
ENSMUST00000163507.8 ENSMUST00000230445.2 |
Pfkm
|
phosphofructokinase, muscle |
chr8_+_23629046 | 12.90 |
ENSMUST00000121075.8
|
Ank1
|
ankyrin 1, erythroid |
chr7_+_101060093 | 12.76 |
ENSMUST00000084894.15
|
Gm45837
|
predicted gene 45837 |
chr6_+_47221293 | 12.69 |
ENSMUST00000199100.5
|
Cntnap2
|
contactin associated protein-like 2 |
chr18_+_61096660 | 12.54 |
ENSMUST00000039904.7
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr9_+_50664288 | 12.51 |
ENSMUST00000214962.2
ENSMUST00000216755.2 |
Cryab
|
crystallin, alpha B |
chr13_+_83652352 | 12.28 |
ENSMUST00000198916.5
ENSMUST00000200123.5 ENSMUST00000005722.14 ENSMUST00000163888.8 |
Mef2c
|
myocyte enhancer factor 2C |
chr16_-_31133622 | 12.26 |
ENSMUST00000115230.2
ENSMUST00000130560.8 |
Apod
|
apolipoprotein D |
chr11_+_71640739 | 12.25 |
ENSMUST00000150531.2
|
Wscd1
|
WSC domain containing 1 |
chr18_+_61096597 | 12.19 |
ENSMUST00000115295.9
|
Camk2a
|
calcium/calmodulin-dependent protein kinase II alpha |
chr2_-_25360043 | 12.10 |
ENSMUST00000114251.8
|
Ptgds
|
prostaglandin D2 synthase (brain) |
chr6_-_77956499 | 12.09 |
ENSMUST00000159626.8
ENSMUST00000075340.12 ENSMUST00000162273.2 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr7_-_142223662 | 11.96 |
ENSMUST00000228850.2
|
Gm49394
|
predicted gene, 49394 |
chr6_-_77956635 | 11.91 |
ENSMUST00000161846.8
ENSMUST00000160894.8 |
Ctnna2
|
catenin (cadherin associated protein), alpha 2 |
chr9_+_107812873 | 11.91 |
ENSMUST00000035700.14
|
Camkv
|
CaM kinase-like vesicle-associated |
chr18_-_43032535 | 11.87 |
ENSMUST00000120632.2
|
Ppp2r2b
|
protein phosphatase 2, regulatory subunit B, beta |
chr17_+_26036893 | 11.87 |
ENSMUST00000235694.2
|
Fbxl16
|
F-box and leucine-rich repeat protein 16 |
chr6_+_47221372 | 11.84 |
ENSMUST00000060839.8
|
Cntnap2
|
contactin associated protein-like 2 |
chr7_+_16609227 | 11.66 |
ENSMUST00000108493.3
|
Dact3
|
dishevelled-binding antagonist of beta-catenin 3 |
chr18_-_43032359 | 11.65 |
ENSMUST00000117687.8
|
Ppp2r2b
|
protein phosphatase 2, regulatory subunit B, beta |
chr6_-_115228800 | 11.64 |
ENSMUST00000205131.2
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chr9_+_50664207 | 11.61 |
ENSMUST00000034562.9
|
Cryab
|
crystallin, alpha B |
chr2_-_52225763 | 11.57 |
ENSMUST00000238288.2
ENSMUST00000238749.2 |
Neb
|
nebulin |
chr6_-_115229128 | 11.52 |
ENSMUST00000032462.9
|
Timp4
|
tissue inhibitor of metalloproteinase 4 |
chrX_+_72546680 | 11.40 |
ENSMUST00000033744.12
ENSMUST00000088429.8 ENSMUST00000114479.2 |
Atp2b3
|
ATPase, Ca++ transporting, plasma membrane 3 |
chr16_+_91066602 | 11.38 |
ENSMUST00000056882.7
|
Olig1
|
oligodendrocyte transcription factor 1 |
chr2_-_25359752 | 11.29 |
ENSMUST00000114259.3
ENSMUST00000015234.13 |
Ptgds
|
prostaglandin D2 synthase (brain) |
chr10_+_3316505 | 11.20 |
ENSMUST00000217573.2
|
Ppp1r14c
|
protein phosphatase 1, regulatory inhibitor subunit 14C |
chr2_+_31985528 | 11.20 |
ENSMUST00000057423.6
ENSMUST00000140762.2 |
Plpp7
|
phospholipid phosphatase 7 (inactive) |
chr11_+_31950496 | 11.16 |
ENSMUST00000093219.4
|
Nsg2
|
neuron specific gene family member 2 |
chr11_-_69496655 | 11.13 |
ENSMUST00000047889.13
|
Atp1b2
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
chr2_-_151474391 | 11.00 |
ENSMUST00000137936.2
ENSMUST00000146172.8 ENSMUST00000094456.10 ENSMUST00000148755.8 ENSMUST00000109875.8 ENSMUST00000028951.14 ENSMUST00000109877.10 |
Snph
|
syntaphilin |
chr7_+_126549692 | 10.68 |
ENSMUST00000106335.8
ENSMUST00000146017.3 |
Sez6l2
|
seizure related 6 homolog like 2 |
chr11_+_121325739 | 10.62 |
ENSMUST00000026175.9
ENSMUST00000092302.11 ENSMUST00000103014.4 |
Fn3k
|
fructosamine 3 kinase |
chr16_-_67417768 | 10.54 |
ENSMUST00000114292.8
ENSMUST00000120898.8 |
Cadm2
|
cell adhesion molecule 2 |
chr6_+_107506678 | 10.48 |
ENSMUST00000049285.10
|
Lrrn1
|
leucine rich repeat protein 1, neuronal |
chr2_+_70392351 | 10.41 |
ENSMUST00000094934.11
|
Gad1
|
glutamate decarboxylase 1 |
chr17_+_35455532 | 10.37 |
ENSMUST00000068261.9
|
Atp6v1g2
|
ATPase, H+ transporting, lysosomal V1 subunit G2 |
chr11_-_59073635 | 10.21 |
ENSMUST00000108793.9
|
Gjc2
|
gap junction protein, gamma 2 |
chr8_+_106412905 | 10.18 |
ENSMUST00000213019.2
|
Carmil2
|
capping protein regulator and myosin 1 linker 2 |
chr7_-_45750153 | 10.13 |
ENSMUST00000180081.3
|
Kcnj11
|
potassium inwardly rectifying channel, subfamily J, member 11 |
chr11_-_61344818 | 10.12 |
ENSMUST00000060255.14
ENSMUST00000054927.14 ENSMUST00000102661.4 |
Rnf112
|
ring finger protein 112 |
chr1_+_9671388 | 10.11 |
ENSMUST00000088666.4
|
Vxn
|
vexin |
chr8_+_23629080 | 9.96 |
ENSMUST00000033947.15
|
Ank1
|
ankyrin 1, erythroid |
chr18_-_43032514 | 9.84 |
ENSMUST00000236238.2
|
Ppp2r2b
|
protein phosphatase 2, regulatory subunit B, beta |
chr15_+_83676140 | 9.79 |
ENSMUST00000172115.8
ENSMUST00000172398.2 |
Mpped1
|
metallophosphoesterase domain containing 1 |
chr8_+_23629173 | 9.75 |
ENSMUST00000174435.2
|
Ank1
|
ankyrin 1, erythroid |
chr1_+_167426019 | 9.73 |
ENSMUST00000111386.8
ENSMUST00000111384.8 |
Rxrg
|
retinoid X receptor gamma |
chr11_+_102727122 | 9.72 |
ENSMUST00000021302.15
ENSMUST00000107072.2 |
Higd1b
|
HIG1 domain family, member 1B |
chr11_-_6015538 | 9.71 |
ENSMUST00000101585.10
ENSMUST00000066431.14 ENSMUST00000109815.9 ENSMUST00000109812.9 ENSMUST00000101586.3 ENSMUST00000093355.12 ENSMUST00000019133.11 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II, beta |
chr7_+_91321694 | 9.69 |
ENSMUST00000238608.2
|
Dlg2
|
discs large MAGUK scaffold protein 2 |
chrX_-_132589727 | 9.68 |
ENSMUST00000149154.8
|
Pcdh19
|
protocadherin 19 |
chr14_+_123897383 | 9.67 |
ENSMUST00000049681.14
|
Itgbl1
|
integrin, beta-like 1 |
chr15_-_71599664 | 9.59 |
ENSMUST00000022953.10
|
Fam135b
|
family with sequence similarity 135, member B |
chr5_-_135280063 | 9.57 |
ENSMUST00000062572.3
|
Fzd9
|
frizzled class receptor 9 |
chrX_+_100492684 | 9.47 |
ENSMUST00000033674.6
|
Itgb1bp2
|
integrin beta 1 binding protein 2 |
chr7_+_91321500 | 9.42 |
ENSMUST00000238619.2
ENSMUST00000238467.2 |
Dlg2
|
discs large MAGUK scaffold protein 2 |
chr19_-_45804446 | 9.32 |
ENSMUST00000079431.10
ENSMUST00000026247.13 ENSMUST00000162528.9 |
Kcnip2
|
Kv channel-interacting protein 2 |
chr5_+_35915217 | 9.26 |
ENSMUST00000101280.10
ENSMUST00000054598.12 ENSMUST00000114205.8 ENSMUST00000114206.9 |
Ablim2
|
actin-binding LIM protein 2 |
chr6_+_21215472 | 9.23 |
ENSMUST00000081542.6
|
Kcnd2
|
potassium voltage-gated channel, Shal-related family, member 2 |
chrX_-_135769285 | 9.20 |
ENSMUST00000058814.7
|
Rab9b
|
RAB9B, member RAS oncogene family |
chr3_-_127202693 | 9.20 |
ENSMUST00000182078.9
|
Ank2
|
ankyrin 2, brain |
chr8_+_106002772 | 9.17 |
ENSMUST00000014920.8
|
Nol3
|
nucleolar protein 3 (apoptosis repressor with CARD domain) |
chr15_-_74544409 | 9.11 |
ENSMUST00000023268.14
ENSMUST00000110009.4 |
Arc
|
activity regulated cytoskeletal-associated protein |
chr7_+_126810780 | 9.06 |
ENSMUST00000032910.13
|
Mylpf
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chrX_-_7439082 | 9.04 |
ENSMUST00000132788.2
|
Ppp1r3f
|
protein phosphatase 1, regulatory subunit 3F |
chr8_+_55003359 | 9.01 |
ENSMUST00000033918.4
|
Asb5
|
ankyrin repeat and SOCs box-containing 5 |
chr9_-_77255099 | 8.99 |
ENSMUST00000184138.8
ENSMUST00000184006.8 ENSMUST00000185144.8 ENSMUST00000034910.16 |
Mlip
|
muscular LMNA-interacting protein |
chr13_-_49301407 | 8.91 |
ENSMUST00000162581.8
ENSMUST00000110097.9 ENSMUST00000049265.15 ENSMUST00000035538.13 ENSMUST00000110096.8 ENSMUST00000091623.10 |
Wnk2
|
WNK lysine deficient protein kinase 2 |
chr17_-_52133594 | 8.90 |
ENSMUST00000129667.8
ENSMUST00000169480.8 ENSMUST00000148559.2 |
Satb1
|
special AT-rich sequence binding protein 1 |
chr14_-_49763310 | 8.84 |
ENSMUST00000146164.2
ENSMUST00000138884.8 ENSMUST00000074368.11 ENSMUST00000123534.2 |
Slc35f4
|
solute carrier family 35, member F4 |
chr11_+_70548622 | 8.77 |
ENSMUST00000170716.8
|
Eno3
|
enolase 3, beta muscle |
chr7_-_45750050 | 8.72 |
ENSMUST00000209291.2
|
Kcnj11
|
potassium inwardly rectifying channel, subfamily J, member 11 |
chr3_+_31204069 | 8.72 |
ENSMUST00000046174.8
|
Cldn11
|
claudin 11 |
chr3_+_136375839 | 8.53 |
ENSMUST00000070198.14
|
Ppp3ca
|
protein phosphatase 3, catalytic subunit, alpha isoform |
chr8_-_126625029 | 8.52 |
ENSMUST00000047239.13
ENSMUST00000131127.3 |
Pcnx2
|
pecanex homolog 2 |
chr17_-_24752683 | 8.51 |
ENSMUST00000061764.14
|
Rab26
|
RAB26, member RAS oncogene family |
chr10_-_80649315 | 8.48 |
ENSMUST00000181039.8
ENSMUST00000180438.2 |
Jsrp1
|
junctional sarcoplasmic reticulum protein 1 |
chr3_+_65016750 | 8.43 |
ENSMUST00000049230.11
|
Kcnab1
|
potassium voltage-gated channel, shaker-related subfamily, beta member 1 |
chr3_-_151971391 | 8.41 |
ENSMUST00000199470.5
ENSMUST00000200589.5 |
Nexn
|
nexilin |
chr1_-_132294807 | 8.40 |
ENSMUST00000136828.3
|
Tmcc2
|
transmembrane and coiled-coil domains 2 |
chr5_+_35915290 | 8.39 |
ENSMUST00000114204.8
ENSMUST00000129347.8 |
Ablim2
|
actin-binding LIM protein 2 |
chr14_+_103887644 | 8.35 |
ENSMUST00000069443.14
|
Slain1
|
SLAIN motif family, member 1 |
chr17_-_37334240 | 8.33 |
ENSMUST00000102665.11
|
Mog
|
myelin oligodendrocyte glycoprotein |
chr9_-_77255069 | 8.31 |
ENSMUST00000184848.8
ENSMUST00000184415.8 |
Mlip
|
muscular LMNA-interacting protein |
chr18_+_57266123 | 8.29 |
ENSMUST00000075770.13
|
Megf10
|
multiple EGF-like-domains 10 |
chr5_-_49682106 | 8.26 |
ENSMUST00000176191.8
|
Kcnip4
|
Kv channel interacting protein 4 |
chr10_-_128204545 | 8.22 |
ENSMUST00000220027.2
|
Coq10a
|
coenzyme Q10A |
chr7_+_45289391 | 8.11 |
ENSMUST00000148532.4
|
Mamstr
|
MEF2 activating motif and SAP domain containing transcriptional regulator |
chr7_+_126396779 | 8.09 |
ENSMUST00000205324.2
|
Tlcd3b
|
TLC domain containing 3B |
chr6_+_104469751 | 8.05 |
ENSMUST00000161446.2
ENSMUST00000161070.8 ENSMUST00000089215.12 |
Cntn6
|
contactin 6 |
chr1_+_74894069 | 8.03 |
ENSMUST00000160379.4
|
Cdk5r2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
chr3_-_127202635 | 8.02 |
ENSMUST00000182959.8
|
Ank2
|
ankyrin 2, brain |
chr12_+_51640097 | 7.99 |
ENSMUST00000164782.10
ENSMUST00000085412.7 |
Coch
|
cochlin |
chr1_-_135302971 | 7.99 |
ENSMUST00000041240.4
|
Shisa4
|
shisa family member 4 |
chr4_+_130297132 | 7.97 |
ENSMUST00000105993.4
|
Nkain1
|
Na+/K+ transporting ATPase interacting 1 |
chr17_-_37334091 | 7.95 |
ENSMUST00000167275.3
|
Mog
|
myelin oligodendrocyte glycoprotein |
chr17_+_81251997 | 7.94 |
ENSMUST00000025092.5
|
Tmem178
|
transmembrane protein 178 |
chr13_+_83652150 | 7.94 |
ENSMUST00000198199.5
|
Mef2c
|
myocyte enhancer factor 2C |
chr12_-_119202527 | 7.87 |
ENSMUST00000026360.9
|
Itgb8
|
integrin beta 8 |
chrX_+_47608122 | 7.87 |
ENSMUST00000033430.3
|
Rab33a
|
RAB33A, member RAS oncogene family |
chrX_+_113384008 | 7.83 |
ENSMUST00000113371.8
ENSMUST00000040504.12 |
Klhl4
|
kelch-like 4 |
chr7_-_74958121 | 7.82 |
ENSMUST00000085164.7
|
Sv2b
|
synaptic vesicle glycoprotein 2 b |
chr7_-_74959010 | 7.77 |
ENSMUST00000165175.8
|
Sv2b
|
synaptic vesicle glycoprotein 2 b |
chr7_-_125681577 | 7.76 |
ENSMUST00000073935.7
|
Gsg1l
|
GSG1-like |
chr9_-_29874401 | 7.76 |
ENSMUST00000075069.11
|
Ntm
|
neurotrimin |
chr2_-_113659360 | 7.71 |
ENSMUST00000024005.8
|
Scg5
|
secretogranin V |
chr13_+_83652280 | 7.71 |
ENSMUST00000199450.5
|
Mef2c
|
myocyte enhancer factor 2C |
chr6_+_54406588 | 7.68 |
ENSMUST00000132855.8
ENSMUST00000126637.8 |
Wipf3
|
WAS/WASL interacting protein family, member 3 |
chr1_+_75526225 | 7.66 |
ENSMUST00000154101.8
|
Slc4a3
|
solute carrier family 4 (anion exchanger), member 3 |
chr5_-_113044216 | 7.66 |
ENSMUST00000086617.11
|
Myo18b
|
myosin XVIIIb |
chrX_+_142301572 | 7.65 |
ENSMUST00000033640.14
|
Pak3
|
p21 (RAC1) activated kinase 3 |
chr5_+_34153328 | 7.61 |
ENSMUST00000056355.9
|
Nat8l
|
N-acetyltransferase 8-like |
chr10_+_81093110 | 7.59 |
ENSMUST00000117488.8
ENSMUST00000105328.10 ENSMUST00000121205.8 |
Matk
|
megakaryocyte-associated tyrosine kinase |
chr2_+_70392491 | 7.58 |
ENSMUST00000148210.8
|
Gad1
|
glutamate decarboxylase 1 |
chr3_+_68491487 | 7.57 |
ENSMUST00000182997.3
|
Schip1
|
schwannomin interacting protein 1 |
chr2_-_113883285 | 7.56 |
ENSMUST00000090269.7
|
Actc1
|
actin, alpha, cardiac muscle 1 |
chr11_+_77384234 | 7.52 |
ENSMUST00000037285.10
ENSMUST00000100812.4 |
Git1
|
GIT ArfGAP 1 |
chr13_-_92268156 | 7.49 |
ENSMUST00000151408.9
ENSMUST00000216219.2 |
Rasgrf2
|
RAS protein-specific guanine nucleotide-releasing factor 2 |
chr12_-_100486950 | 7.40 |
ENSMUST00000223020.2
ENSMUST00000062957.8 |
Ttc7b
|
tetratricopeptide repeat domain 7B |
chr18_-_74197970 | 7.39 |
ENSMUST00000159162.2
ENSMUST00000091851.10 |
Mapk4
|
mitogen-activated protein kinase 4 |
chr7_+_80707328 | 7.36 |
ENSMUST00000107348.2
|
Alpk3
|
alpha-kinase 3 |
chr8_+_46111703 | 7.34 |
ENSMUST00000134675.8
ENSMUST00000139869.8 ENSMUST00000126067.8 |
Sorbs2
|
sorbin and SH3 domain containing 2 |
chr14_-_20596580 | 7.32 |
ENSMUST00000022355.11
ENSMUST00000161445.8 ENSMUST00000159027.8 |
Ppp3cb
|
protein phosphatase 3, catalytic subunit, beta isoform |
chr13_-_95581335 | 7.28 |
ENSMUST00000045583.9
|
Crhbp
|
corticotropin releasing hormone binding protein |
chr11_+_87473027 | 7.28 |
ENSMUST00000133202.3
|
Septin4
|
septin 4 |
chr6_-_124410452 | 7.26 |
ENSMUST00000124998.2
ENSMUST00000238807.2 |
Clstn3
|
calsyntenin 3 |
chr11_+_7013422 | 7.26 |
ENSMUST00000020706.5
|
Adcy1
|
adenylate cyclase 1 |
chr10_-_78188153 | 7.25 |
ENSMUST00000001240.12
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr5_-_49682150 | 7.22 |
ENSMUST00000087395.11
|
Kcnip4
|
Kv channel interacting protein 4 |
chr1_+_128069677 | 7.19 |
ENSMUST00000187023.7
|
R3hdm1
|
R3H domain containing 1 |
chr13_-_95581393 | 7.10 |
ENSMUST00000221025.2
|
Crhbp
|
corticotropin releasing hormone binding protein |
chr6_+_120750510 | 7.10 |
ENSMUST00000112682.4
|
Slc25a18
|
solute carrier family 25 (mitochondrial carrier), member 18 |
chr2_-_52225146 | 7.10 |
ENSMUST00000075301.10
|
Neb
|
nebulin |
chr9_-_112064024 | 7.07 |
ENSMUST00000162097.8
ENSMUST00000159055.8 |
Arpp21
|
cyclic AMP-regulated phosphoprotein, 21 |
chr14_-_55150547 | 7.05 |
ENSMUST00000228495.3
ENSMUST00000228119.3 ENSMUST00000050772.10 ENSMUST00000231305.2 |
Slc22a17
|
solute carrier family 22 (organic cation transporter), member 17 |
chr17_-_57394718 | 7.04 |
ENSMUST00000071135.6
|
Tubb4a
|
tubulin, beta 4A class IVA |
chr13_-_103233323 | 7.00 |
ENSMUST00000166336.9
ENSMUST00000239261.2 ENSMUST00000194446.7 |
Mast4
|
microtubule associated serine/threonine kinase family member 4 |
chr1_+_75351914 | 6.99 |
ENSMUST00000087122.12
|
Speg
|
SPEG complex locus |
chr14_-_24054927 | 6.98 |
ENSMUST00000145596.3
|
Kcnma1
|
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr2_-_170248421 | 6.95 |
ENSMUST00000154650.8
|
Bcas1
|
breast carcinoma amplified sequence 1 |
chr9_+_121589044 | 6.91 |
ENSMUST00000093772.4
|
Zfp651
|
zinc finger protein 651 |
chrX_-_23132991 | 6.89 |
ENSMUST00000115316.9
|
Klhl13
|
kelch-like 13 |
chr1_-_134883577 | 6.83 |
ENSMUST00000168381.8
|
Ppp1r12b
|
protein phosphatase 1, regulatory subunit 12B |
chr9_+_75093177 | 6.81 |
ENSMUST00000129281.8
ENSMUST00000148144.8 ENSMUST00000130384.2 |
Myo5a
|
myosin VA |
chr10_+_29087658 | 6.81 |
ENSMUST00000213489.2
|
9330159F19Rik
|
RIKEN cDNA 9330159F19 gene |
chr5_-_34445662 | 6.79 |
ENSMUST00000094868.10
|
Zfyve28
|
zinc finger, FYVE domain containing 28 |
chr14_-_55354392 | 6.77 |
ENSMUST00000022819.13
|
Jph4
|
junctophilin 4 |
chr6_-_148345834 | 6.76 |
ENSMUST00000060095.15
ENSMUST00000100772.10 |
Tmtc1
|
transmembrane and tetratricopeptide repeat containing 1 |
chr7_+_126811831 | 6.76 |
ENSMUST00000127710.3
|
Mylpf
|
myosin light chain, phosphorylatable, fast skeletal muscle |
chr2_-_25209107 | 6.75 |
ENSMUST00000114318.10
ENSMUST00000114310.10 ENSMUST00000114308.10 ENSMUST00000114317.10 ENSMUST00000028335.13 ENSMUST00000114314.10 ENSMUST00000114307.8 |
Grin1
|
glutamate receptor, ionotropic, NMDA1 (zeta 1) |
chr11_+_68582731 | 6.71 |
ENSMUST00000102611.10
|
Myh10
|
myosin, heavy polypeptide 10, non-muscle |
chr10_+_29087602 | 6.70 |
ENSMUST00000092627.6
|
9330159F19Rik
|
RIKEN cDNA 9330159F19 gene |
chr1_+_167425953 | 6.62 |
ENSMUST00000015987.10
|
Rxrg
|
retinoid X receptor gamma |
chr8_-_74080101 | 6.59 |
ENSMUST00000119826.7
ENSMUST00000212459.2 |
Large1
|
LARGE xylosyl- and glucuronyltransferase 1 |
chr15_-_78657640 | 6.59 |
ENSMUST00000018313.6
|
Mfng
|
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.8 | 41.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
8.6 | 25.8 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
7.3 | 22.0 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
6.2 | 55.9 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
5.6 | 22.5 | GO:1990927 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
5.4 | 21.7 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
5.3 | 26.6 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
5.2 | 31.2 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
5.0 | 20.0 | GO:0098961 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
4.8 | 33.8 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
4.8 | 14.3 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
4.7 | 18.7 | GO:0021586 | pons maturation(GO:0021586) |
4.7 | 18.7 | GO:2000405 | negative regulation of T cell migration(GO:2000405) |
4.6 | 23.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
3.9 | 23.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
3.6 | 14.5 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
3.6 | 14.4 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
3.4 | 10.2 | GO:2000813 | negative regulation of barbed-end actin filament capping(GO:2000813) |
3.4 | 47.4 | GO:0098953 | receptor diffusion trapping(GO:0098953) postsynaptic neurotransmitter receptor diffusion trapping(GO:0098970) neurotransmitter receptor diffusion trapping(GO:0099628) |
3.2 | 9.7 | GO:0060466 | activation of meiosis involved in egg activation(GO:0060466) |
3.2 | 12.8 | GO:1904453 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
3.1 | 9.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
2.9 | 5.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
2.8 | 8.5 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
2.7 | 16.5 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
2.6 | 13.0 | GO:0061622 | glycolytic process through glucose-1-phosphate(GO:0061622) |
2.6 | 18.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.6 | 18.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
2.5 | 7.6 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
2.4 | 17.0 | GO:0061743 | motor learning(GO:0061743) |
2.4 | 7.2 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
2.4 | 14.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
2.4 | 16.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
2.4 | 42.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
2.4 | 7.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
2.3 | 7.0 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
2.3 | 27.9 | GO:0003185 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
2.2 | 20.2 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.2 | 33.0 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
2.2 | 10.9 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
2.1 | 32.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
2.1 | 8.5 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) negative regulation of cerebellar granule cell precursor proliferation(GO:0021941) |
2.1 | 31.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
2.1 | 6.2 | GO:1902938 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
2.0 | 22.2 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
2.0 | 23.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
1.9 | 5.6 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
1.8 | 7.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
1.8 | 5.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
1.8 | 7.3 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.8 | 18.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.8 | 8.9 | GO:0048691 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
1.8 | 19.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.8 | 7.1 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
1.7 | 8.6 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.7 | 6.8 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
1.7 | 1.7 | GO:0099541 | trans-synaptic signaling by lipid(GO:0099541) trans-synaptic signaling by endocannabinoid(GO:0099542) |
1.7 | 5.0 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
1.6 | 6.6 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
1.6 | 6.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.6 | 17.5 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
1.6 | 9.5 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
1.6 | 6.3 | GO:1900623 | positive regulation of mast cell cytokine production(GO:0032765) regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
1.6 | 3.1 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
1.5 | 6.1 | GO:0021750 | cerebellar molecular layer development(GO:0021679) vestibular nucleus development(GO:0021750) |
1.5 | 4.5 | GO:0006233 | dTDP biosynthetic process(GO:0006233) dTDP metabolic process(GO:0046072) |
1.5 | 4.5 | GO:0015882 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.5 | 10.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
1.4 | 2.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
1.4 | 6.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
1.4 | 2.7 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
1.3 | 16.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
1.3 | 10.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
1.3 | 10.2 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
1.3 | 5.0 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
1.3 | 3.8 | GO:0019085 | early viral transcription(GO:0019085) |
1.2 | 6.2 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.2 | 4.9 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
1.2 | 6.1 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
1.2 | 3.6 | GO:0006867 | asparagine transport(GO:0006867) positive regulation of glutamine transport(GO:2000487) |
1.2 | 3.6 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
1.2 | 15.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
1.2 | 5.9 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
1.2 | 5.8 | GO:0044849 | estrous cycle(GO:0044849) |
1.2 | 7.0 | GO:0034465 | response to carbon monoxide(GO:0034465) eye blink reflex(GO:0060082) |
1.2 | 4.6 | GO:0014894 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.1 | 2.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.1 | 4.6 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
1.1 | 4.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.1 | 5.5 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
1.1 | 8.8 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.1 | 3.3 | GO:0019405 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
1.0 | 4.2 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
1.0 | 7.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.0 | 5.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
1.0 | 1.0 | GO:1903233 | regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) |
1.0 | 6.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.0 | 2.9 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.0 | 3.9 | GO:0099612 | protein localization to axon(GO:0099612) |
1.0 | 3.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 4.9 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
1.0 | 14.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
1.0 | 5.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.9 | 2.8 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.9 | 2.7 | GO:0021664 | rhombomere formation(GO:0021594) rhombomere 3 formation(GO:0021660) rhombomere 5 morphogenesis(GO:0021664) rhombomere 5 formation(GO:0021666) |
0.9 | 8.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.9 | 8.9 | GO:2000651 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.9 | 2.7 | GO:0098749 | cerebellar neuron development(GO:0098749) |
0.9 | 10.6 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.9 | 3.5 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.9 | 5.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.9 | 7.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.9 | 2.6 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) regulation of T-helper 17 cell lineage commitment(GO:2000328) |
0.9 | 2.6 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) negative regulation of forebrain neuron differentiation(GO:2000978) |
0.9 | 9.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.8 | 2.5 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.8 | 3.4 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.8 | 2.5 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.8 | 3.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.8 | 4.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.8 | 10.6 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.8 | 6.4 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) |
0.8 | 2.4 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.8 | 15.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.8 | 11.8 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.8 | 3.8 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.8 | 35.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.8 | 6.0 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.7 | 35.0 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.7 | 25.4 | GO:0060074 | synapse maturation(GO:0060074) |
0.7 | 2.1 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.7 | 8.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.7 | 7.0 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.7 | 9.7 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 6.9 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.7 | 3.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.7 | 5.4 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.7 | 16.3 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
0.7 | 2.7 | GO:0032972 | regulation of muscle filament sliding(GO:0032971) regulation of muscle filament sliding speed(GO:0032972) |
0.7 | 4.6 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.7 | 7.3 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.7 | 3.3 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
0.7 | 6.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 1.3 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
0.6 | 4.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.6 | 7.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 3.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 1.9 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 13.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.6 | 3.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.6 | 6.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 9.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.6 | 11.1 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.6 | 4.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 5.5 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.6 | 1.8 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.6 | 9.0 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.6 | 7.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 22.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 6.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.6 | 7.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.6 | 4.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.6 | 3.5 | GO:0006537 | glutamate biosynthetic process(GO:0006537) glutamine catabolic process(GO:0006543) |
0.6 | 4.0 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.6 | 8.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.6 | 23.4 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.6 | 29.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.6 | 15.9 | GO:0033198 | response to ATP(GO:0033198) |
0.6 | 5.7 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.6 | 2.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.6 | 4.5 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
0.6 | 5.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.6 | 5.6 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.6 | 2.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.6 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 3.3 | GO:0060596 | mammary placode formation(GO:0060596) |
0.5 | 15.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.5 | 14.8 | GO:0045214 | sarcomere organization(GO:0045214) |
0.5 | 5.5 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.5 | 1.6 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 1.1 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.5 | 1.6 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
0.5 | 2.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.5 | 10.6 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.5 | 13.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 1.6 | GO:1902868 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
0.5 | 3.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.5 | 19.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 5.7 | GO:0030578 | PML body organization(GO:0030578) |
0.5 | 2.1 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.5 | 3.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.5 | GO:0036145 | dendritic cell homeostasis(GO:0036145) |
0.5 | 2.6 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.5 | 23.5 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.5 | 2.0 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 7.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 6.9 | GO:0048102 | autophagic cell death(GO:0048102) |
0.5 | 2.0 | GO:0044805 | late nucleophagy(GO:0044805) |
0.5 | 12.8 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.5 | 4.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.5 | 41.2 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.5 | 11.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.5 | 5.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.5 | 4.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.5 | 4.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.5 | 1.4 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.5 | 1.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.5 | 2.4 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.5 | 1.4 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.5 | 10.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.5 | 3.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 5.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.8 | GO:0045186 | zonula adherens assembly(GO:0045186) |
0.4 | 2.2 | GO:0098957 | anterograde axonal transport of mitochondrion(GO:0098957) |
0.4 | 4.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.4 | 2.7 | GO:0071484 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.4 | 4.3 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 2.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.4 | 8.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.4 | 2.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.4 | 2.1 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.4 | 7.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.4 | 1.2 | GO:1901003 | regulation of fermentation(GO:0043465) negative regulation of fermentation(GO:1901003) |
0.4 | 1.2 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 2.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.4 | 1.2 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.4 | 1.6 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.4 | 5.9 | GO:0045188 | regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
0.4 | 2.3 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.4 | 4.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.4 | 8.7 | GO:0001553 | luteinization(GO:0001553) |
0.4 | 0.4 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.4 | 0.4 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.4 | 7.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.4 | 1.1 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.4 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.4 | 1.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.4 | 6.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 5.1 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 3.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.8 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.4 | 8.7 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.4 | 1.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.4 | 4.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.3 | 1.0 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
0.3 | 3.8 | GO:2000582 | regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.3 | 2.1 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 2.8 | GO:0031179 | peptide modification(GO:0031179) |
0.3 | 7.3 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 3.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 19.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.3 | 11.5 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.3 | 6.6 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.3 | 26.9 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.3 | 5.7 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.3 | 0.9 | GO:0007356 | thorax and anterior abdomen determination(GO:0007356) mastication(GO:0071626) learned vocalization behavior(GO:0098583) |
0.3 | 6.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 3.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.3 | 4.3 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.3 | 2.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 0.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.3 | 17.6 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
0.3 | 3.1 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.3 | 4.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 1.2 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.3 | 3.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.3 | 1.8 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.3 | 2.4 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 0.6 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
0.3 | 5.3 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.3 | 0.9 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.3 | 2.0 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 3.1 | GO:0051966 | regulation of synaptic transmission, glutamatergic(GO:0051966) |
0.3 | 1.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 4.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.3 | 2.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.3 | 3.0 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.3 | 1.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.3 | 11.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.3 | 0.8 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.3 | 4.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.3 | 6.3 | GO:0048747 | muscle fiber development(GO:0048747) |
0.3 | 3.4 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.3 | 1.0 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.3 | 7.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.3 | 1.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.3 | 1.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 10.0 | GO:0031111 | negative regulation of microtubule depolymerization(GO:0007026) negative regulation of microtubule polymerization or depolymerization(GO:0031111) regulation of microtubule depolymerization(GO:0031114) |
0.2 | 2.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 7.2 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 3.7 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.2 | 2.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.2 | 4.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.2 | 6.3 | GO:0022038 | corpus callosum development(GO:0022038) |
0.2 | 1.9 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 9.0 | GO:0090662 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 1.7 | GO:2000774 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
0.2 | 1.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 4.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 5.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.2 | 5.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 8.5 | GO:0006821 | chloride transport(GO:0006821) |
0.2 | 16.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.2 | 1.2 | GO:0009624 | response to nematode(GO:0009624) |
0.2 | 1.2 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.2 | 1.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 2.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 1.8 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) negative regulation of neutrophil activation(GO:1902564) |
0.2 | 3.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 0.4 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 1.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 8.8 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 4.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.2 | 5.9 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.2 | 6.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.2 | 1.9 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 3.6 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 4.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 5.6 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
0.2 | 5.0 | GO:0043113 | receptor clustering(GO:0043113) |
0.2 | 8.8 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 1.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 11.0 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 3.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 2.1 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 2.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.2 | 2.5 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.2 | 0.8 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.2 | 0.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 2.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.2 | 9.7 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.2 | 0.4 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.2 | 7.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.2 | 10.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.2 | 7.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 4.0 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.2 | 5.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.2 | 0.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 8.0 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 0.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.8 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.2 | 1.2 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 7.3 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
0.2 | 1.8 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.2 | 9.5 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.2 | 1.8 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 13.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.6 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.2 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.2 | 2.9 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.2 | 0.2 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.1 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.4 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.1 | 1.2 | GO:0097039 | CD40 signaling pathway(GO:0023035) protein linear polyubiquitination(GO:0097039) |
0.1 | 8.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 1.6 | GO:0098780 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.1 | 2.5 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.1 | 27.3 | GO:0050808 | synapse organization(GO:0050808) |
0.1 | 8.2 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.3 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.1 | 1.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.4 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 1.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.7 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.9 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.4 | GO:1905168 | positive regulation of double-strand break repair via homologous recombination(GO:1905168) |
0.1 | 2.7 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.1 | 0.5 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 2.1 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.1 | 2.5 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.1 | 0.4 | GO:0090238 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) positive regulation of arachidonic acid secretion(GO:0090238) |
0.1 | 22.3 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.1 | 0.5 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.7 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.1 | 0.6 | GO:0042711 | maternal behavior(GO:0042711) |
0.1 | 1.1 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 3.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 6.0 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 2.6 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
0.1 | 0.3 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 1.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 2.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.1 | 5.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.8 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.7 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.9 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 2.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.1 | 2.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.1 | 1.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.1 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.1 | 5.7 | GO:1902017 | regulation of cilium assembly(GO:1902017) |
0.1 | 5.0 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.1 | 1.7 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 1.6 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.1 | 17.1 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 3.6 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 2.4 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.1 | 2.6 | GO:0030032 | lamellipodium assembly(GO:0030032) |
0.1 | 0.2 | GO:0033605 | positive regulation of norepinephrine secretion(GO:0010701) positive regulation of catecholamine secretion(GO:0033605) |
0.1 | 1.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 6.1 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 9.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.1 | 3.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 0.3 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 2.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 1.6 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 1.5 | GO:0034205 | beta-amyloid formation(GO:0034205) |
0.1 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 1.8 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.1 | GO:2000118 | sodium-dependent phosphate transport(GO:0044341) regulation of sodium-dependent phosphate transport(GO:2000118) |
0.1 | 2.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.8 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.1 | 0.7 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.6 | GO:0048278 | vesicle docking(GO:0048278) |
0.1 | 3.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 1.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.4 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 2.1 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.1 | 6.5 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 1.8 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.1 | 0.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 2.1 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.0 | 0.8 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.4 | GO:0032231 | regulation of actin filament bundle assembly(GO:0032231) |
0.0 | 0.6 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 3.8 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.0 | 0.4 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.0 | 0.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
0.0 | 1.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.5 | GO:0003157 | endocardium development(GO:0003157) |
0.0 | 3.9 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.1 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.0 | 2.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 1.3 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 1.2 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.0 | 0.2 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 1.0 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.3 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.0 | 0.5 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 1.9 | GO:0048709 | oligodendrocyte differentiation(GO:0048709) |
0.0 | 4.6 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.0 | 5.2 | GO:0034765 | regulation of ion transmembrane transport(GO:0034765) |
0.0 | 2.5 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.4 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 1.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.4 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.3 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 2.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.3 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.0 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 2.0 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
0.0 | 0.6 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.7 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.0 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.0 | 0.6 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 2.4 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 2.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 2.4 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.5 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.0 | 0.2 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.5 | GO:0032418 | lysosome localization(GO:0032418) |
0.0 | 0.1 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.9 | 47.4 | GO:0099573 | glutamatergic postsynaptic density(GO:0099573) |
10.0 | 29.9 | GO:0043512 | inhibin A complex(GO:0043512) |
7.3 | 22.0 | GO:0060205 | secretory granule lumen(GO:0034774) cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
5.9 | 29.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
3.2 | 12.8 | GO:1990794 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
3.1 | 156.0 | GO:0031430 | M band(GO:0031430) |
2.6 | 26.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
2.6 | 13.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
2.6 | 18.1 | GO:0005955 | calcineurin complex(GO:0005955) |
2.6 | 2.6 | GO:0044301 | climbing fiber(GO:0044301) |
2.5 | 7.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
2.1 | 31.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
2.0 | 8.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.0 | 7.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
1.9 | 67.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.9 | 5.6 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
1.8 | 12.9 | GO:0097513 | myosin II filament(GO:0097513) |
1.8 | 9.2 | GO:0044307 | dendritic branch(GO:0044307) |
1.7 | 45.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
1.7 | 29.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
1.7 | 6.8 | GO:0042642 | actomyosin, myosin complex part(GO:0042642) |
1.7 | 5.0 | GO:0044317 | rod spherule(GO:0044317) |
1.6 | 6.4 | GO:0060171 | stereocilium membrane(GO:0060171) |
1.5 | 49.8 | GO:0031672 | A band(GO:0031672) |
1.5 | 6.0 | GO:0008091 | spectrin(GO:0008091) |
1.5 | 5.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
1.3 | 3.9 | GO:0098855 | HCN channel complex(GO:0098855) |
1.2 | 3.7 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
1.2 | 9.6 | GO:0031527 | filopodium membrane(GO:0031527) |
1.1 | 11.1 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.1 | 35.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.0 | 18.9 | GO:0070852 | cell body fiber(GO:0070852) |
1.0 | 54.4 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
1.0 | 7.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
1.0 | 4.9 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
1.0 | 3.9 | GO:1990769 | proximal neuron projection(GO:1990769) |
1.0 | 2.9 | GO:1904602 | serotonin-activated cation-selective channel complex(GO:1904602) |
1.0 | 7.7 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 2.9 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.9 | 5.5 | GO:0071547 | piP-body(GO:0071547) |
0.9 | 7.0 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.9 | 39.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.9 | 15.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.8 | 6.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.8 | 1.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.8 | 12.4 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.8 | 11.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.8 | 4.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.8 | 15.9 | GO:0005767 | secondary lysosome(GO:0005767) |
0.7 | 5.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.7 | 63.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.7 | 18.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.6 | 4.2 | GO:0070695 | FHF complex(GO:0070695) |
0.6 | 7.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.6 | 2.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.6 | 17.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 10.5 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 6.1 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 6.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.5 | 14.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.5 | 6.9 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 40.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.5 | 2.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 12.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 2.3 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.5 | 10.0 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 10.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.4 | 4.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.4 | 37.5 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.4 | 1.7 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 2.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.4 | 6.2 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.4 | 37.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.4 | 17.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.4 | 12.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.4 | 1.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 17.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.3 | 2.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 3.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 96.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 8.2 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.3 | 4.2 | GO:0032982 | myosin filament(GO:0032982) |
0.3 | 2.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.3 | 1.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.3 | 2.8 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.3 | 2.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.3 | 1.2 | GO:0071797 | LUBAC complex(GO:0071797) |
0.3 | 3.3 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.3 | 39.7 | GO:0016605 | PML body(GO:0016605) |
0.3 | 53.7 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.3 | 2.6 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 0.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.3 | 5.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 3.4 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 63.4 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 1.8 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 12.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 6.4 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 2.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 5.0 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.2 | 3.6 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 4.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.2 | 17.7 | GO:0043679 | axon terminus(GO:0043679) |
0.2 | 31.5 | GO:0043209 | myelin sheath(GO:0043209) |
0.2 | 6.3 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 5.0 | GO:0097440 | apical dendrite(GO:0097440) |
0.2 | 5.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.2 | 9.7 | GO:0043197 | dendritic spine(GO:0043197) |
0.1 | 3.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 30.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 3.4 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 2.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 0.5 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 12.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 1.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 1.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 2.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.1 | 3.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 1.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.1 | 1.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 2.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 2.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 2.3 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.9 | GO:0070187 | telosome(GO:0070187) |
0.1 | 0.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.5 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.6 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 2.2 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.5 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 2.5 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.8 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 3.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 1.1 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 32.0 | GO:0005874 | microtubule(GO:0005874) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.1 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.1 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.9 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 9.8 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 27.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.1 | 13.0 | GO:0030016 | myofibril(GO:0030016) |
0.1 | 0.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.3 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.1 | 5.5 | GO:0005814 | centriole(GO:0005814) |
0.1 | 2.5 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.8 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 7.3 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.5 | GO:0070847 | core mediator complex(GO:0070847) |
0.1 | 2.2 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 29.7 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 6.8 | GO:0045202 | synapse(GO:0045202) |
0.0 | 1.1 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.0 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.7 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.1 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.3 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 2.1 | GO:0001650 | fibrillar center(GO:0001650) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.1 | 42.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
10.1 | 30.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
7.4 | 29.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
5.8 | 23.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
4.8 | 14.4 | GO:0051424 | corticotropin-releasing hormone binding(GO:0051424) |
4.6 | 13.7 | GO:0004134 | glycogen debranching enzyme activity(GO:0004133) 4-alpha-glucanotransferase activity(GO:0004134) amylo-alpha-1,6-glucosidase activity(GO:0004135) |
4.2 | 16.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
4.0 | 15.8 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
3.8 | 23.0 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
3.7 | 18.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
3.6 | 47.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
3.6 | 32.8 | GO:0034711 | inhibin binding(GO:0034711) |
3.4 | 34.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
3.1 | 21.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
3.0 | 18.1 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
2.8 | 8.5 | GO:0019002 | GMP binding(GO:0019002) |
2.8 | 27.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
2.7 | 10.8 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
2.6 | 13.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
2.6 | 18.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
2.4 | 18.9 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.2 | 6.6 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
2.2 | 26.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
2.1 | 25.2 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.1 | 6.2 | GO:0099530 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
2.0 | 12.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.0 | 20.2 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.0 | 6.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
1.9 | 7.5 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
1.8 | 7.4 | GO:0035827 | rubidium ion transmembrane transporter activity(GO:0035827) |
1.8 | 9.0 | GO:2001069 | glycogen binding(GO:2001069) |
1.7 | 5.2 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
1.6 | 16.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.6 | 4.9 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
1.5 | 9.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.5 | 4.5 | GO:0004798 | thymidylate kinase activity(GO:0004798) |
1.5 | 4.5 | GO:0008520 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
1.5 | 17.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
1.5 | 32.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.5 | 5.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.4 | 10.1 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.4 | 5.5 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
1.4 | 23.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
1.3 | 10.7 | GO:1904315 | transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
1.3 | 8.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
1.3 | 6.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.3 | 10.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
1.3 | 27.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 8.9 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.3 | 10.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
1.3 | 10.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.2 | 4.9 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
1.2 | 15.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 7.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
1.2 | 8.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.1 | 2.3 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.1 | 4.6 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
1.1 | 5.6 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.1 | 53.7 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 7.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
1.0 | 5.1 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.0 | 27.2 | GO:0003680 | AT DNA binding(GO:0003680) |
1.0 | 17.1 | GO:0005522 | profilin binding(GO:0005522) |
1.0 | 19.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.0 | 17.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 6.6 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.9 | 2.8 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 3.6 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
0.9 | 3.5 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.9 | 7.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.9 | 5.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.9 | 7.8 | GO:0030955 | potassium ion binding(GO:0030955) |
0.9 | 4.3 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.8 | 3.4 | GO:0045183 | translation factor activity, non-nucleic acid binding(GO:0045183) |
0.8 | 5.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.8 | 20.9 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.8 | 25.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.8 | 2.5 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.8 | 11.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.8 | 10.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.8 | 7.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.8 | 3.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.8 | 6.2 | GO:0005499 | vitamin D binding(GO:0005499) |
0.8 | 16.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.8 | 9.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.8 | 3.1 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.8 | 3.0 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.7 | 11.2 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.7 | 3.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.7 | 5.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.7 | 20.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.7 | 28.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.7 | 2.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.7 | 5.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.7 | 17.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.7 | 19.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.7 | 6.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 6.9 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.7 | 2.8 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.7 | 4.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.7 | 5.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.7 | 61.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.7 | 3.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.6 | 2.6 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.6 | 3.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.6 | 2.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.6 | 5.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.6 | 2.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.6 | 8.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 6.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.6 | 3.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.6 | 13.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.6 | 2.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.6 | 8.8 | GO:0038191 | neuropilin binding(GO:0038191) |
0.6 | 12.1 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 19.0 | GO:0005112 | Notch binding(GO:0005112) |
0.5 | 2.7 | GO:0051373 | FATZ binding(GO:0051373) |
0.5 | 4.8 | GO:0031432 | titin binding(GO:0031432) |
0.5 | 8.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.5 | 6.6 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.5 | 14.0 | GO:0016917 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
0.5 | 2.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.5 | 12.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.5 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.5 | 4.0 | GO:0070061 | fructose binding(GO:0070061) |
0.5 | 9.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.5 | 4.8 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.5 | 1.4 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.5 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.5 | 1.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.4 | 4.9 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.4 | 4.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 24.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 4.8 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.4 | 2.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.4 | 6.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.4 | 21.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.4 | 3.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.4 | 2.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.4 | 7.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 1.7 | GO:0032093 | SAM domain binding(GO:0032093) |
0.4 | 3.6 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.4 | 5.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.4 | 2.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.4 | 2.7 | GO:0031013 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
0.4 | 1.1 | GO:0016901 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.5 | GO:0071796 | K6-linked polyubiquitin binding(GO:0071796) |
0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 7.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.4 | 29.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.4 | 10.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.4 | 2.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.4 | 8.2 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.4 | 7.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.4 | 7.0 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.4 | 11.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.3 | 5.8 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.3 | 1.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 3.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.3 | 2.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.9 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.3 | 0.3 | GO:0052596 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.3 | 8.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.3 | 15.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.3 | 6.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 11.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 1.1 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 16.9 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 45.0 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 1.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 5.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.2 | 4.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 5.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 18.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.2 | 3.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 2.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.2 | 2.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.2 | 8.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.2 | 14.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 1.9 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.2 | 2.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 3.8 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 5.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 5.7 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 0.6 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.2 | 3.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 1.8 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 2.8 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 19.6 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 1.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 2.1 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 4.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 1.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 4.2 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.2 | 6.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 4.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 1.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 1.3 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 3.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 0.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.2 | 2.6 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 3.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 3.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 6.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 6.6 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 14.1 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 6.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 5.3 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.1 | 4.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.3 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 21.6 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 11.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 10.2 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.1 | 5.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.1 | 2.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.7 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 10.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 5.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 5.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 2.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 1.8 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 15.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.4 | GO:0000010 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.1 | 3.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 12.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 3.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 3.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 2.1 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 2.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.1 | 5.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 15.3 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.1 | 0.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 2.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 1.7 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 1.7 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.3 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 7.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 2.6 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 2.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 4.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 3.9 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.8 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 0.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 20.2 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) RNA polymerase II activity(GO:0001055) |
0.1 | 3.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.3 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.8 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.4 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 0.4 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 38.3 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.1 | 0.7 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 3.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 1.5 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 0.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 11.1 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.1 | 0.3 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.8 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 2.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 1.9 | GO:0005254 | chloride channel activity(GO:0005254) |
0.0 | 0.4 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 1.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 18.7 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.6 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 1.1 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.0 | GO:0034046 | poly(G) binding(GO:0034046) |
0.0 | 1.2 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 10.4 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 1.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.3 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.7 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 1.0 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.0 | 0.3 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0019807 | aspartoacylase activity(GO:0019807) |
0.0 | 0.1 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 58.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.2 | 55.5 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.7 | 18.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.7 | 4.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.6 | 29.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.6 | 33.4 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 11.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 11.8 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.5 | 4.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 20.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 13.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.4 | 0.4 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.3 | 7.9 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 36.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.3 | 7.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.3 | 5.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.3 | 10.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 2.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.3 | 2.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.2 | 2.7 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 9.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 8.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.2 | 11.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 0.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.2 | 68.0 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 9.5 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 17.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.2 | 2.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 13.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 5.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 5.1 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 4.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 2.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 18.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.5 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 3.0 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 4.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 4.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 4.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 20.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 9.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.7 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 12.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.5 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.9 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.3 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 2.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.1 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 29.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
2.6 | 84.3 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
2.2 | 51.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
1.9 | 7.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
1.6 | 81.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.9 | 15.4 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.8 | 19.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.8 | 13.1 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.8 | 37.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.7 | 20.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.7 | 18.0 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 39.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 10.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.6 | 10.1 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.6 | 33.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 26.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.6 | 19.3 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.5 | 21.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.5 | 20.7 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.5 | 6.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.5 | 7.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.5 | 5.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.5 | 5.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.5 | 4.5 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 11.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 3.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.4 | 7.1 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.4 | 5.3 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.4 | 24.4 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.4 | 6.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.4 | 2.6 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.4 | 19.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 9.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 2.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 5.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.3 | 9.9 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 6.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.3 | 6.6 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.3 | 12.0 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 5.0 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.3 | 13.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.3 | 5.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 8.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.2 | 2.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.2 | 3.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.2 | 12.7 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.2 | 16.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 2.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 4.8 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 3.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.2 | 3.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 5.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 4.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 2.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 2.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.1 | 1.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 10.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 5.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 3.3 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 2.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 24.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.1 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.9 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 33.8 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 4.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 2.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 2.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.2 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.1 | 2.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 4.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 10.7 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.1 | 3.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.1 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 2.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 1.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.1 | 4.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 1.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 2.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.0 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.4 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.0 | 1.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |